|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO
|
[dexamethasone 21-phosphate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein
|
CTD |
PMID:29782964 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G
|
Bdkrb1
|
bradykinin receptor B1
|
multiple interactions
|
ISO
|
dexamethasone 21-phosphate inhibits the reaction [IL1B protein promotes the reaction [kallidin, des-Arg(10)- binds to BDKRB1 protein]]; dexamethasone 21-phosphate inhibits the reaction [TNF protein promotes the reaction [kallidin, des-Arg(10)- binds to BDKRB1 protein]]
|
CTD |
PMID:17931716 |
|
NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747
|
|
G
|
Blk
|
BLK proto-oncogene, Src family tyrosine kinase
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of BLK mRNA]
|
CTD |
PMID:36996615 |
|
NCBI chr15:37,626,746...37,665,053
Ensembl chr15:37,627,039...37,665,031
|
|
G
|
Blnk
|
B-cell linker
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of BLNK protein]
|
CTD |
PMID:36996615 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions
|
EXP ISO
|
dexamethasone 21-phosphate results in increased cleavage of and results in increased activity of CASP3 protein
|
CTD |
PMID:25447644 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G
|
Cd19
|
CD19 molecule
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of CD19 protein]
|
CTD |
PMID:36996615 |
|
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
|
|
G
|
Cd22
|
CD22 molecule
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of CD22 mRNA]
|
CTD |
PMID:36996615 |
|
NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:86,117,459...86,132,322
|
|
G
|
Fabp4
|
fatty acid binding protein 4
|
multiple interactions
|
ISO
|
[dexamethasone 21-phosphate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein
|
CTD |
PMID:29782964 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G
|
Fcgr2b
|
Fc gamma receptor 2B
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of FCGR2B mRNA]
|
CTD |
PMID:36996615 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G
|
Fcrla
|
Fc receptor-like A
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of FCRLA mRNA]
|
CTD |
PMID:36996615 |
|
NCBI chr13:83,160,453...83,170,170
Ensembl chr13:83,160,398...83,170,762
|
|
G
|
Il10
|
interleukin 10
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in decreased expression of IL10 protein]
|
CTD |
PMID:36996615 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions
|
ISO
|
dexamethasone 21-phosphate inhibits the reaction [IL1B protein affects the localization of RELA protein]; dexamethasone 21-phosphate inhibits the reaction [IL1B protein promotes the reaction [kallidin, des-Arg(10)- binds to BDKRB1 protein]]
|
CTD |
PMID:17931716 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
|
CTD |
PMID:36996615 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G
|
Ins2
|
insulin 2
|
multiple interactions
|
ISO
|
[dexamethasone 21-phosphate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [dexamethasone 21-phosphate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein
|
CTD |
PMID:29782964 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G
|
Ms4a1
|
membrane spanning 4-domains A1
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of MS4A1 protein]
|
CTD |
PMID:36996615 |
|
NCBI chr 1:207,906,370...207,927,028
Ensembl chr 1:207,906,374...207,918,512
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
increases cleavage
|
ISO
|
dexamethasone 21-phosphate results in increased cleavage of PARP1 protein
|
CTD |
PMID:25447644 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G
|
Pou2af1
|
POU class 2 homeobox associating factor 1
|
multiple interactions
|
EXP
|
dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of POU2AF1 mRNA]
|
CTD |
PMID:36996615 |
|
NCBI chr 8:51,521,813...51,548,819
Ensembl chr 8:51,474,015...51,548,819
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions affects localization
|
ISO
|
dexamethasone 21-phosphate inhibits the reaction [IL1B protein affects the localization of RELA protein] dexamethasone 21-phosphate affects the localization of RELA protein
|
CTD |
PMID:17931716 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G
|
Serpinb1a
|
serpin family B member 1A
|
multiple interactions
|
EXP ISO
|
dexamethasone 21-phosphate results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form dexamethasone 21-phosphate results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form
|
CTD |
PMID:25447644 |
|
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO EXP
|
dexamethasone 21-phosphate inhibits the reaction [TNF protein promotes the reaction [kallidin, des-Arg(10)- binds to BDKRB1 protein]] dexamethasone 21-phosphate inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
|
CTD |
PMID:17931716 PMID:36996615 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|